Live Breaking News & Updates on Wafra Inc

Stay updated with breaking news from Wafra inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Evoke Wealth LLC Makes New $1.36 Million Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […] ....

United States , Michaelj Labarre , Norges Bank , Exchange Commission , Securities Exchange Commission , International Assets Investment Management , Wafra Inc , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Evoke Wealth , Halozyme Therapeutics , Free Report , Assets Investment Management , Capital Management , Get Free Report , Halozyme Therapeutics Daily ,

Wafra wins Euromoney award

Wafra wins Euromoney award
royalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from royalgazette.com Daily Mail and Mail on Sunday newspapers.

United Arab Emirates , Ron Solenske , Wafra Inc , Islamic Fund , New York Headquartered , Best Islamic Fund Manager , Euromoney Islamic Finance Awards , Elias Scheker Da Silva , Scheker Da Silva , Islamic Finance , Euromoney Middle East Awards ,

Halozyme Therapeutics' (HALO) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. TD Cowen began coverage on shares of […] ....

United States , Michaelj Labarre , Halozyme Therapeutics Company Profile , Wafra Inc , Hsbc Holdings , International Assets Investment Management , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Halozyme Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Assets Investment Management , Capital Management , Get Free Report , Halozyme Therapeutics Daily ,

HC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. JMP Securities cut their target price on shares of […] ....

United States , Michaelj Labarre , Hsbc Holdings , Wafra Inc , International Assets Investment Management , Securities Exchange Commission , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Halozyme Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Assets Investment Management , Capital Management , Halozyme Therapeutics Daily ,